Cite

    Johnston, S. et al. (2019). Body mass index and insulin use as identifiers of high‐cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data. Diabetes, obesity & metabolism. 21 (6), pp. 1419-1428. [Online].